CASP1 and polycystic ovary syndrome: Using western blot and immunofluorescence staining, we observed that FMN treatment reversed the upregulated expression of NLRP3, ASC and caspase-1 induced by DHEA and DHT in rats and cells, indicating that FMN administration could inhibit NLRP3 inflammasome activation in PCOS rat and cell models.